Citation: | PEI Jianghong, XIAO Yu, Li Qixing, ZHAO Zihao, CHEN Li. Synthesis and antitumor activity of novel CDDO derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(5): 548-553. DOI: 10.11665/j.issn.1000-5048.20170507 |
[1] |
Pollier J,Goossens A.Oleanolic acid[J].Phytochemistry,2012,77(5):10-15.
|
[2] |
Sporn MB,Liby KT,Yore MM,et al.New synthetic triterpenoids:potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress[J].J Nat Prod,2011,74(3):537-545.
|
[3] |
Liby KT,Sporn MB.Synthetic oleanane triterpenoids:multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease[J].Pharmacol Rev,2012,64(4):972-1003.
|
[4] |
Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer[J].Nat Rev Cancer,2007,7(5):357-369.
|
[5] |
Liby K,Yore MM,Roebuck BD,et al.A novel acetylenic tricyclic bis-(cyano enone)potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin[J].Cancer Res,2008,68(16):6727-6733.
|
[6] |
Hong DS,Kurzrock R,Supko JG,et al.A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas[J].Clin Cancer Res,2012,18(12):3396-3406.
|
[7] |
Pergola PE,Raskin P,Toto RD,et al.Bardoxolone methyl and kidney function in CKD with type 2 diabetes[J].N Engl J Med,2011,365(4):327-336.
|
[8] |
Chartoumpekis DV, Sykiotis GP. Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease[J].N Engl J Med,2014,370(18):1767-1769.
|
[9] |
de Zeeuw D,Akizawa T,Audhya P,et al.Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease[J].N Engl J Med,2013,369(26):2492-2503.
|
[10] |
Taylor RD,MacCoss M,Lawson ADG.Rings in drugs[J].J Med Chem,2014,57(14):5845-5859.
|
[11] |
Xiao Y,Luo QF,Li QX,et al.Improved synthesis of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid[J].Chin J Med Chem(中国药物化学杂志),2016,26(2):131-135.
|
[12] |
Liu Y,Wang TT,Chen L.Synthesis and antitumor activity of isosteviol derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(1):48-53.
|
[1] | YE Chenglian, CHEN Jincong, LIU Chenfu. Recent progress of enzymatic synthesis of flavonoid C-glycosides with C-glycosyltransferase[J]. Journal of China Pharmaceutical University, 2024, 55(4): 463-471. DOI: 10.11665/j.issn.1000-5048.2024042901 |
[2] | JIA Yifei, WANG Yamei, LI Gongyu. Recent progress of protein glycosylation characterization utilizing native conformer-resolved mass spectrometry[J]. Journal of China Pharmaceutical University, 2023, 54(6): 674-681. DOI: 10.11665/j.issn.1000-5048.2023060901 |
[3] | WU Yue, CHEN Yijun. Recent progress of functional impacts of ubiquitin-like modifications on ribosomal proteins[J]. Journal of China Pharmaceutical University, 2022, 53(5): 507-517. DOI: 10.11665/j.issn.1000-5048.20220501 |
[4] | LI Chengfei, CHEN Ling, WU Xuri. Regio-selective glycosylation of mogroside IIIE by glycosyltransferase[J]. Journal of China Pharmaceutical University, 2019, 50(2): 222-229. DOI: 10.11665/j.issn.1000-5048.20190214 |
[5] | HU Yulong, HONG Wenrong. C-6′aminomethylation modification in gentamicin biosynthesis gene cluster[J]. Journal of China Pharmaceutical University, 2015, 46(1): 105-110. DOI: 10.11665/j.issn.1000-5048.20150116 |
[6] | SHI Xuanwen, LI Mengxi, LI Hang, LI Ji′an, CHEN Daijie, SHAO Lei. Effect of gene disruption of snogE encoding glycosyltransferase on nogalamycin biosynthesis[J]. Journal of China Pharmaceutical University, 2013, 44(5): 460-464. DOI: 10.11665/j.issn.1000-5048.20130515 |
[7] | WANG Yuanxi, CHEN Junsheng, SHAO Lei, LI Ji′an, LIN Huimin, CHEN Daijie. Heterologous expression and in vitro activity of vancomycin glycosyltransferase GtfE[J]. Journal of China Pharmaceutical University, 2013, 44(3): 272-276. DOI: 10.11665/j.issn.1000-5048.20130317 |
[9] | YANG Ya-Bo, WANG Min, LIANG Yan, LIANG Jing-Yu. Transgalactosylation of Isotaxiresinol by[J]. Journal of China Pharmaceutical University, 2002, (6). |
[10] | Effect of ADP-Ribosylation on Transcriptional Activities in Nuclei from Rat Liver and Spleen[J]. Journal of China Pharmaceutical University, 1991, (4): 229-232. |